Results 151 to 160 of about 11,407 (242)

Developing a framework to assess off-patent medicines policies in Latin America and the Caribbean. [PDF]

J Pharm Policy Pract
Espín J, Palacio-Ciro S, Amaris A, Gongora-Salazar P, Wirtz VJ.   +4 more
europepmc   +1 more source

The Place of Biosimilars in the Therapeutic Strategy in Patients with Moderate-to-Severe Plaque Psoriasis

According to European guidelines and the Diagnostic and Therapeutic Recommendations of the Polish Dermatological Society (Polskiego Towarzystwa Dermatologicznego, PTD), the therapeutic goal of the treatment of plaque psoriasis is currently full or almost
Adam Reich, Maciej Pastuszczak, Joanna Narbutt, Julia M. Feldman, Agnieszka B. Owczarczyk-Saczonek, Jacek Szepietowski, Aleksandra Lesiak, Witold Owczarek, Irena Walecka   +8 more
core   +1 more source

Biological Medicines, Biosimilars and Their Automatic Substitution: Concerns, Knowledge and Information Needs of People with Diabetes. [PDF]

BioDrugs
Kouhia M, Linden K, Metso S, Pimiä E, Koski S, Aarnio E, Zacheus T, Hämeen-Anttila K.   +7 more
europepmc   +1 more source

Perceptions and clinical use of biosimilars among rheumatologists in ArLAR countries: a cross-sectional survey. [PDF]

Front Med (Lausanne)
Adnan A, Awadh NI, Humadi YA, Gorial FI, Ziade N, Younis AA, Hmamouchi I, El Kibbi L, Halabi H, Haouichat C, Masri BK, Omer EOH, Shimal AA, Al-Obaidi AD, Jassim NA.   +14 more
europepmc   +1 more source

Pragmatic health technology appraisals of biosimilars: a pilot case study of bevacizumab in colorectal cancer for NICE. [PDF]

Cost Eff Resour Alloc
Stevenson MD, Mon-Yee M, Forsyth JE, Montazeri A, Saunders MP.   +4 more
europepmc   +1 more source

Managed care perspectives on biosimilars

, 2011
Annual spending on biopharmaceuticals in the United States (2011) is over $60 billion and rising much faster than traditional chemical pharmaceuticals.
Myers, Bruce E.
core  

Biosimilars in Adult and Pediatric Noninfectious Uveitis. [PDF]

Clin Ophthalmol
Ploeger CG, Carvalho Soares Valentim C, Guner ME, Kabaalioglu Guner M.   +3 more
europepmc   +1 more source

Health literacy and biosimilar acceptance in people with multiple sclerosis: a cross-sectional study. [PDF]

BMC Nurs
Pastore F, Cicolini G, Forastefano B, Domenicone E, De Summa S, Comparcini D, Simonetti V.   +6 more
europepmc   +1 more source

Pulmonary Hypertension Following the Use of Trastuzumab Biosimilars. [PDF]

Case Rep Pulmonol
Ojo T, Cablay K, Emara N, Meyer A.
europepmc   +1 more source

Shaping the future of retinal care in India: Anti-VEGF therapy now and beyond. [PDF]

Indian J Ophthalmol
Karpe A, Narula R, Shroff D, Roy A.
europepmc   +1 more source